Merck names Isabel De Paoli as chief strategy officer of new strategy unit

Germany’s Merck KGaA (MRK: DE) has appointed Isabel De Paoli as chief strategy officer effective October 1, 2016.

Ms De Paoli will head the newly-created group strategy and transformation function, integrating existing strategy, innovation and digitalization initiatives across Merck. She will assume the new role in addition to her current position as head of group communications for the time being and continue to report to Stefan Oschmann, chief executive and chairman of the executive board of Merck.

“Over the past year, we’ve started to explore a variety of very promising innovation and digitalization projects to deliver on our promise as a science and technology,” Mr Oschmann said. “Going forward, we will integrate those initiatives in a coherent strategy to ensure swift and successful implementation. Isabel De Paoli has built a strong track record in defining strategies and setting up organizations that yield efficient and effective returns – most recently in her role as head of group communications, successfully streamlining the organization to support strategic objectives of our Healthcare, Life Science and Performance Materials businesses,” he added.